Symbol="ACAD"
AssetType="Common Stock"
Name="ACADIA Pharmaceuticals Inc"
Description="ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company is headquartered in San Diego, California."
CIK="1070494"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3903000000"
EBITDA="-162228000"
PERatio="None"
PEGRatio="-0.42"
BookValue="2.305"
DividendPerShare="0"
DividendYield="0"
EPS="-0.91"
RevenuePerShareTTM="3.212"
ProfitMargin="-0.281"
OperatingMarginTTM="-0.316"
ReturnOnAssetsTTM="-0.16"
ReturnOnEquityTTM="-0.356"
RevenueTTM="520229000"
GrossProfitTTM="145494000"
DilutedEPSTTM="-0.91"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.026"
AnalystTargetPrice="24.77"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.771"
PriceToBookRatio="6.0"
EVToRevenue="4.265"
EVToEBITDA="-9.91"
Beta="0.525"
num_52WeekHigh="26.04"
num_52WeekLow="13.73"
num_50DayMovingAverage="23.17"
num_200DayMovingAverage="18.87"
SharesOutstanding="162625000"
DividendDate="None"
ExDividendDate="None"
symbol="ACAD"
open="23.97"
high="24.31"
low="23.67"
price="24.16"
volume="1040217.00"
latest_trading_day="2023-07-05"
previous_close="24.00"
change="0.16"
change_percent="0.6667%"
aroon_positive_momentum_days="86"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="86"
Volume_recent_avg="1499674"
Change_recent_avg="0.03"
Delta_recent_avg="0.73"
Variance_recent_avg="0.36"
Change_ratio_recent_avg="0.1"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="86"
Aroon_momentum_negative="14"
image_negative_thumbnail_id_1="487"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0118.jpeg"
image_negative_thumbnail_id_2="121"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_neutral_thumbnail_id_1="534"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0065.jpeg"
image_neutral_thumbnail_id_2="589"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_positive_thumbnail_id_1="642"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_positive_thumbnail_id_2="689"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_professor_thumbnail_id_1="1190"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
